Comprehensive evaluation of immune function in patients receiving multimodal therapy for high-risk neuroblastoma
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210348
- Recipient
-
University Health Network UEI ENZFJ8Q5KX39
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,419,453
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from USAspending.gov.
About this award
The University Health Network will receive $1,419,453 under a Project Grant award from the Department of the Army Medical Command to conduct a comprehensive evaluation of immune function in patients receiving multimodal therapy for high-risk neuroblastoma. Funded through the Military Medical Research and Development program (CFDA 12.420), this four-year award beginning September 1, 2022 will support applied research investigating medical solutions for neuroblastoma on the battlefield and transforming patient care through innovative immunological research. The Place of Performance for this award is the University Health Network facilities in Ottawa, Canada, where researchers will analyze immune responses in neuroblastoma patients undergoing various treatment regimens to identify new therapeutic targets and improve long-term outcomes.
Quick answers
Who received award W81XWH2210348?
W81XWH2210348 was awarded to University Health Network by Medical Command (Department of the Army) on September 1, 2022.
How much is award W81XWH2210348 worth?
$1,419,453 has been obligated on W81XWH2210348.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award